Mannkind (MNKD) Cost of Revenue (2015 - 2026)
Mannkind's (MNKD) quarterly Cost of Revenue came in at $7.5 million in Q1 2026, up 99.28% year-on-year from $3.8 million in Q1 2025, and down 46.08% on a QoQ basis from $13.9 million in Q4 2025.
Mannkind (MNKD) Cost of Revenue (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has 12 years of Cost of Revenue data on file, last reported at $7.5 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 99.28% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $30.5 million, a 75.75% increase from a year earlier, with the FY2025 full-year figure at $26.8 million, up 53.77% from the prior year.
- Cost of Revenue for Q1 2026 stood at $7.5 million, down from $13.9 million in the prior quarter.
- Over the last five years, Cost of Revenue for MNKD reached as high as $15.9 million in Q2 2022 and fell as low as -$19.9 million in Q4 2023.
- Historically, Cost of Revenue has averaged $6.0 million across 5 years, with a median of $5.2 million in 2023.
- Across the five-year window, Cost of Revenue soared 259.74% in 2022 and plunged 587.36% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $4.1 million in 2022, then plunged by 587.36% to -$19.9 million in 2023, then surged by 124.17% to $4.8 million in 2024, then jumped by 189.66% to $13.9 million in 2025, then tumbled by 46.08% to $7.5 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $7.5 million in Q1 2026, $13.9 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mannkind | 1.23 Bn | 1.10 Bn | 82.66 Mn | 7.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.51 Mn |
| Mar 31, 2026 | 7.51 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Dec 31, 2025 | 13.93 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Dec 31, 2023 | -19.89 Mn |
| Dec 31, 2023 | -19.89 Mn |